본문 바로가기
KERD
논문KCI 등재

인간 골격근세포주(HM4)에서 Interleukin-6 생성에 대한 정맥내 글로불린의 효과

Effect of Intravenous Immuoglobulin on Interleukin-6 Production in Human Skeletal Muscle Cell Line (HM4)

이용범|주인수|김성희|주억식
대한신경과학회 (Korean Neurological Association)|2004.06|대한신경과학회지 (Journal of the Korean Neurological Association)|제22권 제3호|pp. 249-254

0

조회

0

다운로드

0

인용

0

참고문헌

주제분류신경과학

초록

Abstract

Background: Intravenous immunoglobulin (IVIg) has been widely used in the management of patients with various autoimmune neurological diseases, however, its action mechanisms have not fully been elucidated yet. This study focused on the effects of IVIg on the production of interleukin-6 (IL-6), one of major proinflammatory cytokine, using a human skeletal muscle cell line (HM4). Methods: After HM4 cells were cultured in Dulbecco's modified eagle's medium (DMEM) containing 5% fetal bovine serum for 24 h, the culture medium was changed with serum-free media. TNF-α (tumor necrosis factor-α, 100 ng/mL) and IVIg (5 mg/mL) were treated alone or in combination and cultured for various time. RT-PCR and ELISA kit were employed for mRNA expression and secretion of IL-6, respectively. Results: Treatment with TNF-α or/and IVIg significantly induced IL-6 mRNA expression (p<0.001). Although IL-6 production was markedly increased by TNF-α (p<0.001), IVIg treatment alone or in combination with TNF-α had no effect on the production of IL-6 except at 6 h after the treatment. Conclusions: IVIg seems not to have a significant effect on IL-6 production as an action mechanism of its immunomodulatory capabilities, at least in the HM4 cell line.

참고문헌 (39)

  1. "High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood", 1, pp.1228~1231 (1981)
  2. "Clinical uses of intravenous immunoglobulins", 112, pp.278~292 (1990)
  3. "Manipulating the immune system with immune globulin", 326, pp.107~116 (1992)
  4. "Intravenous immunoglobulin in neurological disease:a specialist review", 72, pp.440~448 (2002)
  5. "Intravenous immune globulin therapy for neurological diseases", 126, pp.721~730 (1997)
  6. "The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders", 23 (2002)
  7. "Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases", 100, pp.151~157 (1997)
  8. "Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases", 51 (1998)
  9. "Human intravenous immunoglobulin modulates monokine production in vitro", 71, pp.372~376 (1990)
  10. "Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production", 72, pp.497~501 (1991)
  11. "Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo", 84, pp.2136~2143 (1994)
  12. "Cytokine modulation with immune gamma- globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment", 21, pp.193~199 (2001)
  13. "Effects of intravenous immunoglobulin on plasma interleukin-10 levels in Kawasaki disease", 62, pp.19~24 (1998)
  14. "Intravenous immunoglobulins and transforming growth factor beta", 351, pp.184~185 (1998)
  15. "The paradigm of IL-6:from basic science to medicine", 4 (2002)
  16. "Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides", 31, pp.784~788 (1988)
  17. "Cytokine expression profile in idiopathic inflammatory myopathies", 55, pp.342~347 (1996)
  18. "Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies", 40, pp.865~874 (1997)
  19. "Analysis of cytokine expression in muscle in inflammatory myopathies,Duchenne dystrophy,and non-weak controls", 63, pp.9~16 (1995)
  20. "The expression of cytokines and chemokine mRNA by human skeletal muscle cell line(SKM14)", 21, pp.89~96 (2003)
  21. "Production of IL-6 by human myoblasts stimulated with Abeta:relevance in the pathogenesis of IBM", 57, pp.1561~1565 (2001)
  22. "Cytokines and chemokines are both expressed by human myoblasts:possible relevance for the immune pathogenesis of muscle inflammation", 12, pp.1329~1335 (2000)
  23. "A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis", 329, pp.1993~2000 (1993)
  24. "Intravenous immunoglobulin induces interferon- gamma and interleukin-6 in vivo", 13, pp.302~309 (1993)
  25. "Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies", 17, pp.704~721 (1986)
  26. "Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment", 88, pp.844~848 (1999)
  27. "Pooled human IgG modulates cytokine production in lymphocytes and monocytes", 139, pp.21~42 (1994)
  28. "Effect of intravenous immunoglobulin G on the TNFalpha-mediated hepatic microvascular inflammatory response", 11, pp.291~295 (1999)
  29. "Local expression of cytokines in idiopathic inflammatory myopathies", 24, pp.73~79 (1998)
  30. "Myoblasts produce IL-6 in response to inflammatory stimuli", 10, pp.267~273 (1998)
  31. "Anti-cytokine nature of natural human immunoglobulin:one possible mechanism of the clinical effect of intravenous immunoglobulin therapy", 139, pp.5~19 (1994)
  32. "Contribution of stabilizing agents present in intravenous immunoglobulin preparations to modulation of mononuclear cell proliferation in vitro", 44, pp.585~591 (1996)
  33. "Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells", 60, pp.4610~4616 (2000)
  34. "IL-6 and APPs:anti- inflammatory and immunosuppresive mediators", 18, pp.428~432 (1997)
  35. "Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist an dsoluble tumor necrosis factor receptor p55", 83, pp.113~118 (1994)
  36. "IL-6 enhnces plasma IL-1ra,IL-10,and cortisol in humans", 285, pp.433~437 (2003)
  37. "Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s)released by activated monocytes", 216, pp.49~53 (1995)
  38. "Continuous activation of gp130,a signal-transducing receptor component for interleukin 6-related cytokines,causes myocardial hypertrophy in mice", 92, pp.4862~4866 (1995)
  39. "Continuous activation of gp130,a signal-transducing receptor component for interleukin 6-related cytokines,causes myocardial hypertrophy in mice", 92, pp.4862~4866 (1995)

관련 논문AI추천

신경근질환의 정맥 내 면역글로불린 치료와 연관된 유해사례나상준, 최영철대한임상신경생리학회 · Annals of Clinical Neurophysiology2006 · 제8권 제1호근조직 및 배양 근세포에서의 Dysferlin 발현과 그 의의이은영, 최영철대한신경과학회 · 대한신경과학회지2007 · 제25권 제4호염증성 근질환의 발병기전이동국대한임상신경생리학회 · Annals of Clinical Neurophysiology2002 · 제4권 제1호흰쥐 골격근의 허혈성 스트레스 조건하에서 NF-κB 활성 변화이정은대한재활의학회 · Annals of Rehabilitation Medicine2003 · 제27권 제6호MG-63 세포주에서 Vascular Endothelial Growth Factor (VEGF) mRNA 발현에 대한Insulin-like Growth Factor I (IGF-I)의 효과에 대한 연구명훈, 강나라, 서제덕, 정필훈대한구강악안면외과학회 · 대한구강악안면외과학회지2005 · 제31권 제5호말초신경병증에 대한 정맥내 면역글로불린 요법김남희, 박경석대한임상신경생리학회 · Annals of Clinical Neurophysiology2006 · 제8권 제1호

이 간행물의 다른 논문 (7건)

안진김지수pp. 177-191전조성 편두통과 호모시스테인 및 MTHFR C677T 유전자 다형성의 상관 관계이일형, 김현조, 서정호, 최병옥, 김옥준pp. 200-205원위부 만성염증성탈수초성다발성신경병증:원위부 근력 약화가 우세한 변형김병준, 배종석pp. 219-225건강한 성인을 대상으로 시행한 신경전도검사의 검사자 내 변이정근호, 문준식, 김승민, 김서현, 정연경, 권순희, 권기한, 남정모, 선우일남, 노숙영, 강사윤pp. 235-239당뇨병성 신경병증 환자에서 관찰되는 탈수초화의 전기생리학적 소견권기한, 황성희, 오미선, 정산, 권석범pp. 240-248
원문 보기